Haddo O, Mahroof S, Higgs D et al 2004 The use of chondroguide membrane in autologous chondrocyte implantation Knee 11 51-55
Knutsen G, Engebretsen L, Ludvigsen T et al 2004 Autologous chondrocyte implantation compared with microfracture in the knee Journal of Bone and Joint Surgery [Am] 860A 455-464
Micheli LJ, Browne JE, Erggelet C, Fu F, Mandelbaum B, Moseley JB, Zurakowski D 2001 Autologous chondrocyte implantation of the knee: multicentre experience and minimum 3-year follow-up Clinical Journal of Sport Medicine 11 223-228
Minas T 2001 Autologous chondrocyte implantation for focal chondral defects of the knee Clinical Orthopaedics 391(Suppl 1) 349-361
Clinical outcome of autologous chondrocyte implantation at 5 years in US subjects.
Repair of large chondral defects of the knee with autologous chondrocyte implantation in patients 45 years or older.
Autologous chondrocyte implantation versus debridement for treatment of full-thickness chondral defects of the knee: an observational cohort study with 3-year follow-up.
Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint.
Therefore, the additional role of autologous chondrocyte implantation benefit is seen.
Autologous chondrocyte implantation is indicated for the treatment of choice for disabling anterior knee pain resulting from large erosive chondral defects (4 to 6 [cm.
Autologous chondrocyte implantation
, a technique developed at Sahlgrenska Hospital, Gothenburg, Sweden, has been shown, through hundreds of cases, to provide clinical benefits for patients suffering from cartilage defects.